In December 2021 Maven Investor Partners completed a profitable exit from Westfield Medical Group. The trade sale to France domiciled Sterimed Group generated a 2.2x total return for investors.
Westfield is one of the UK’s leading providers of single use sterilisation barrier packaging and other sterilisation products to the public and private healthcare and industrial sectors. Its customers include NHS hospital sterile departments, private hospitals, industrial and medical device manufacturers.
Maven led the management buyout of Westfield in 2016. Under the stewardship of CEO James Vero, coupled with the investment and support provided by Maven, the business expanded in the UK and grew its international footprint, with sales into EMEA, Asia and the Americas accounting for over 45% of 2020 revenues
The sale of Westfield represents a good return for our investors. The management team has been instrumental in successfully delivering the organic growth plan in recent years and the business has performed strongly. The sale to the Sterimed Group is a great strategic fit for Westfield with significant opportunities for the two businesses to explore. It has been a pleasure to work with the Westfield management team and we wish them well as the company embarks on the next stage of its growth.
Tom Purkis, Partner at Maven
